PP 2.9 – 00125 Impact of latency reversal agents on estrogen receptor alpha gene and protein expression

• C. Ceriani,
• K.L. Lemu,
• A. Abeyta-Lopez,
• B. Allard,
• K.S. James,
• D.M. Margolis,
• N.M. Archin

Affiliations

C. Ceriani

UNC HIV Cure Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

K.L. Lemu

UNC HIV Cure Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

A. Abeyta-Lopez

UNC HIV Cure Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

B. Allard

UNC HIV Cure Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

K.S. James

UNC HIV Cure Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

D.M. Margolis

UNC HIV Cure Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

N.M. Archin

UNC HIV Cure Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA